VNRX - VolitionRx Limited Company Long-Term Liabilities

Public company logo of volition.com (VNRX)

Market price action on GURU.Markets helps assess the debt load of VolitionRx Limited (VNRX), which currently stands at 0.00. VolitionRx Limited (VNRX) develops innovative AI tests for early oncology diagnostics, leveraging unique patents for nucleosome analysis. Demand for such services remains independent of economic downturns, as it relies on medical protocols. High utilization of modernized production capacities confirms the active commercial development of the business.

VolitionRx Limited (VNRX) Company Long-Term Debt: for the period 07/04/2022 - 10/30/2026

VolitionRx (VNRX) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price VolitionRx Ltd.|VNRX - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation VolitionRx|VNRX - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share VolitionRx|VNRX - Company Book Value|Market Value to Book Value volition.com|VNRX - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio VolitionRx Limited|VNRX - Long-Term Debt to Capital|Short-Term Debt to Capital VolitionRx Ltd.|VNRX - Company Debts|Debt to Book Value Ratio VolitionRx|VNRX - Company Long-Term Debts|Company Short-Term Debts VolitionRx|Quick Liquidity volition.com
- earnings and market multiples details:
VNRX - Net Income
Analysis of all company metrics:VolitionRx Limited - VNRX
Brand item of VolitionRx

This indicator aggregates obligations with maturities exceeding twelve months, reflecting the long-term credit load on the issuer's balance sheet. Assessing the organization's long-term financial debt determines the stability of VolitionRx Limited (VNRX) while scaling Nu.Q AI diagnostics and protecting its patent portfolio, helping investors balance leverage risks against the growth potential of the biopharmaceutical business.

Who VolitionRx Limited competes with

CAI: Company Long-Term Indebtedness|Guardant Health - Company Long-Term Debts|Veracyte Inc (VCYT) - Company Long-Term Liabilities|CELC: Company Long-Term Debts|Long-Term Debt GRAIL Bio (GRAL)|Company Long-Term Debt Myriad Genetics, Inc.|CSTL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities BNR (Burning Rock)|BDSX (Biodesix Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts PRPO (Precipio, Inc)|Company Long-Term Debts Check-Cap Ltd CHEK|MYNZ - Company Long-Term Debt|OCX (oncocyte.com) - Company Long-Term Indebtedness